Xilio Development Stock EBITDA
| XLO Stock | USD 1.09 0.08 7.92% |
Xilio Development fundamentals help investors to digest information that contributes to Xilio Development's financial success or failures. It also enables traders to predict the movement of Xilio Stock. The fundamental analysis module provides a way to measure Xilio Development's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xilio Development stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -73.8 M | -77.5 M |
Xilio | EBITDA |
Xilio Development Company EBITDA Analysis
Xilio Development's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Xilio Development EBITDA | (73.8 M) |
Most of Xilio Development's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xilio Development is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Xilio EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Xilio Development is extremely important. It helps to project a fair market value of Xilio Stock properly, considering its historical fundamentals such as EBITDA. Since Xilio Development's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Xilio Development's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Xilio Development's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Xilio Ebitda
According to the company disclosure, Xilio Development reported earnings before interest,tax, depreciation and amortization of (73.8 Million). This is 108.41% lower than that of the Biotechnology sector and 173.69% lower than that of the Health Care industry. The ebitda for all United States stocks is 101.89% higher than that of the company.
Xilio EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xilio Development's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xilio Development could also be used in its relative valuation, which is a method of valuing Xilio Development by comparing valuation metrics of similar companies.Xilio Development is currently under evaluation in ebitda category among its peers.
Xilio Development Institutional Holders
Institutional Holdings refers to the ownership stake in Xilio Development that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Xilio Development's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Xilio Development's value.| Shares | Blackrock Inc | 2024-06-30 | 66.4 K | State Street Corp | 2024-06-30 | 43.4 K | Sevenbridge Financial Group, Llc | 2024-06-30 | 41 K | Northern Trust Corp | 2024-09-30 | 39.2 K | Raymond James & Associates | 2024-09-30 | 38.8 K | Engineers Gate Manager Lp | 2024-09-30 | 32.8 K | Xtx Topco Ltd | 2024-09-30 | 23.9 K | Honkamp Krueger Financial Services Inc | 2024-09-30 | 20.5 K | Two Sigma Securities, Llc | 2024-06-30 | 13.3 K | Bain Capital Life Sciences Investors, Llc | 2024-09-30 | 4.6 M | Rock Springs Capital Management Lp | 2024-06-30 | 3 M |
Xilio Fundamentals
| Return On Equity | -1.71 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (6.54) % | ||||
| Current Valuation | (8.45 M) | ||||
| Shares Outstanding | 43.96 M | ||||
| Shares Owned By Insiders | 40.92 % | ||||
| Shares Owned By Institutions | 33.50 % | ||||
| Number Of Shares Shorted | 41.96 K | ||||
| Price To Book | 2.12 X | ||||
| Price To Sales | 9.61 X | ||||
| Gross Profit | (56.77 M) | ||||
| EBITDA | (73.8 M) | ||||
| Net Income | (76.4 M) | ||||
| Cash And Equivalents | 159.41 M | ||||
| Cash Per Share | 5.82 X | ||||
| Total Debt | 11.46 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 9.17 X | ||||
| Book Value Per Share | 0.48 X | ||||
| Cash Flow From Operations | (68.62 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (1.55) X | ||||
| Target Price | 4.5 | ||||
| Number Of Employees | 73 | ||||
| Beta | -0.2 | ||||
| Market Capitalization | 44.4 M | ||||
| Total Asset | 60.93 M | ||||
| Retained Earnings | (325.51 M) | ||||
| Working Capital | 103.38 M | ||||
| Net Asset | 60.93 M |
About Xilio Development Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xilio Development's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xilio Development using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xilio Development based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Xilio Development
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xilio Development position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will appreciate offsetting losses from the drop in the long position's value.Moving against Xilio Stock
| 0.72 | ZTS | Zoetis Inc | PairCorr |
| 0.66 | HLN | Haleon plc | PairCorr |
| 0.66 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.6 | LLY | Eli Lilly | PairCorr |
| 0.6 | RDY | Dr Reddys Laboratories | PairCorr |
The ability to find closely correlated positions to Xilio Development could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xilio Development when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xilio Development - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xilio Development to buy it.
The correlation of Xilio Development is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xilio Development can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Xilio Development Piotroski F Score and Xilio Development Altman Z Score analysis. To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xilio Development. If investors know Xilio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xilio Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.55) | Revenue Per Share 0.105 | Return On Assets (0.53) | Return On Equity (1.71) |
The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xilio Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.